Crossmark

Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial

Crossref DOI link: https://doi.org/10.1038/s41443-020-0332-7

Published Online: 2020-07-18

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Palmieri, Alessandro

Arcaniolo, Davide http://orcid.org/0000-0002-5282-2335
Palumbo, Fabrizio

Verze, Paolo

Liguori, Giovanni http://orcid.org/0000-0003-2431-5296
Mondaini, Nicola

Falcone, Marco

Scroppo, Fabrizio Idelfonso

Salonia, Andrea

Cai, Tommaso http://orcid.org/0000-0002-7234-3526
,

Cocci, Andrea

De Sio, Marco

Di Trapani, Danilo

Guerani, Attilio

Italiano, Emilio

Marone, Francesco

Tamanini, Irene

Timpano, Massimiliano

Zucchi, Alessandro
License Information

Text and Data Mining valid from 2020-07-18

Version of Record valid from 2020-07-18
More Information

Article History

Received: 5 May 2019

Revised: 20 June 2020

Accepted: 9 July 2020

First Online: 18 July 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below